The race to develop more effective IL-2 cancer therapies
Immunotherapy was a game-changer for the cancer field, but immunotherapies using cytokines like IL-2 often cause severe side effects. Researchers are developing a newly engineered blueprint to improve the therapeutic efficacy and safety of IL-2 and other cytokines.